A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies

Supportive Care in Cancer

Volumn 21, Issue 9, 2013, Pages 2521-2526

  Samonis, George ^a   Vardakas, Konstantinos Z ^b,c   Maraki, Sofia ^d   Tansarli, Giannoula S ^b   Dimopoulou, Dimitra ^a   Kofteridis, Diamantis P ^a   Andrianaki, Angeliki M ^a   Falagas, Matthew E ^b,c,e  

^a UNIVERSITY OF CRETE   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c MITERA HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood stream infection; Cancer; Neutropenia; Resistance; Tumor

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM ISOLATION; CANCER RECURRENCE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM STAINING; GREECE; HEMATOLOGIC MALIGNANCY; HOSPITAL DISCHARGE; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIDRUG RESISTANCE; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; REINFECTION; RELAPSE; RESPIRATORY TRACT INFECTION; SPECIES DIFFERENCE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

AGED; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HEMATOLOGIC NEOPLASMS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

EID: 84881230729     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1816-5     Document Type: Article

References (37)

1. Who (2011) Who: Causes of death in 2008
2. Rafailidis PI, Kakisi OK, Vardakas K, Falagas ME (2007) Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials. Cancer 109(11):2182-2189 (Pubitemid 46805005)
3. Bliziotis IA, Michalopoulos A, Kasiakou SK et al (2005) Ciprofloxacin vs. an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc 80(9):1146-1156 (Pubitemid 41235474)
4. Samonis G, Koutsounaki E, Karageorgopoulos DE et al (2012) Empirical therapy with ceftazidime combined with levofloxacin or once-daily Amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis 31(7):1389-1398
5. Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME (2005) Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomized controlled trials. Lancet Infect Dis 5(7):431-439 (Pubitemid 40846470)
6. Norgaard M, Larsson H, Pedersen G, Schonheyder HC, Sorensen HT (2006) Hematological malignancies - a predictor of a poor outcome in patients with bacteremia. J Infect 53(3):190-198 (Pubitemid 44227808)
7. Klastersky J (1998) Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 41(Suppl D):13-24 (Pubitemid 28284503)
8. Klastersky J, Ameye L, Maertens J et al (2007) Bacteremia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51-S59 (Pubitemid 47505301)
9. Viscoli C, Cometta A, Kern WV et al (2006) Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clin Microbiol Infect 12(3):212-216 (Pubitemid 43379320)
10. Anatoliotaki M, Valatas V, Mantadakis E et al (2004) Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum, and outcome. Infection 32(2):65-71 (Pubitemid 38457098)
11. Fassas A, Papageorgiou T, Kontodimou A, Proya E, Hadjikyrkou M, Anagnostopoulos A (1989) Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia. J Chemother 1(4 Suppl):1295-1297
12. Roilides E, Sidi V, Gompakis N, Tsivitanidou M, Katsaveli A, Koliouskas D (1998) Patterns and outcome of septicemia in neutropenic children with cancer in a Greek hospital. Infection 26(3):189-191 (Pubitemid 28279259)
13. Who (2010) Who: WHO guidelines on drawing blood: best practices in phlebotomy
14. Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP (2007) Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 146(7):486-492 (Pubitemid 351650557)
15. Institute Nc (2003) Common toxicity criteria for adverse events. In: Cancer therapeutics evaluation program. Bethesda
16. Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268-281
17. Arvanitidou M, Katikaridou E, Douboyas J, Tsakris A (2005) Epidemiological characteristics of nosocomial bacteremias among ICU and non-ICU patients in a tertiary-care hospital in Greece. J Hosp Infect 59(1):70-72 (Pubitemid 39618970)
18. Hadziyannis AS, Stephanou I, Dimarogona K et al (2004) Blood culture results during the period 1995-2002 in a Greek tertiary care hospital. Clin Microbiol Infect 10(7):667-670 (Pubitemid 39077059)
19. Paragioudaki M, Stamouli V, Kolonitsiou F, Anastassiou ED, Dimitracopoulos G, Spiliopoulou I (2004) Intravenous catheter infections associated with bacteremia: a 2-year study in a university hospital. Clin Microbiol Infect 10(5):431-435 (Pubitemid 38714571)
20. Tsitsopoulos PP, Iosifidis E, Antachopoulos C et al (2010) A 5-year epidemiological study of nosocomial bloodstream infections in a neurosurgery department. Infect Control Hosp Epidemiol 31(4):414-417
21. Kang CI, Song JH, Chung DR et al (2012) Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer 10:2371-8
22. Singer C, Kaplan MH, Armstrong D (1977) Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 62(5):731-742 (Pubitemid 8110786)
23. Coullioud D, Van Der Auwera P, Viot M, Lasset C (1993) Prospective multicentric study of the etiology of 1,051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer). Support Care Cancer 1(1):34-46
24. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F (1996) Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 15(4):291-296 (Pubitemid 26159689)
25. Spanik S, Sufliarsky J, Mardiak J et al (1998) Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes. Support Care Cancer 6(3):291-294 (Pubitemid 28213068)
26. Escande MC, Herbrecht R (1998) Prospective study of bacteremia in cancer patients. Results of a French multicentre study. Support Care Cancer 6(3):273-280 (Pubitemid 28213065)
27. Velasco E, Thuler LC, Martins CA, Nucci M, Dias LM, Goncalves VM (2000) Epidemiology of bloodstream infections at a cancer center. Sao Paulo Med J 118(5):131-138
28. Whimbey E, Kiehn TE, Brannon P, Blevins A, Armstrong D (1987) Bacteremia and fungemia in patients with neoplastic disease. Am J Med 82(4):723-730
29. Lowder JN, Lazarus HM, Herzig RH (1982) Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. Arch Intern Med 142(8):1456-1459 (Pubitemid 12048344)
30. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP (1992) Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 11(8):675-682
31. Weinstein MP, Towns ML, Quartey SM et al (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24(4):584-602 (Pubitemid 27143552)
32. Geerdes HF, Ziegler D, Lode H et al (1992) Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 15(6):991-1002
33. Celkan T, Ozkan A, Apak H et al (2002) Bacteremia in childhood cancer. J Trop Pediatr 48(6):373-377 (Pubitemid 36024540)
34. Cherif H, Kronvall G, Bjorkholm M, Kalin M (2003) Bacteremia in hospitalized patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4(6):420-426 (Pubitemid 38088787)
35. Joo EJ, Kang CI, Ha YE et al (2011) Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor. J Infect 63(3):207-214
36. Wang SS, Lee NY, Hsueh PR et al (2011) Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect 44(4):282-288
37. Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME (2012) Predictors of mortality in patients with infections due to multidrug resistant Gram-negative bacteria: the study, the patient, the bug, or the drug? J Infect 66(5):401-14